Personal Information
Occupation
SVP & Chief Compliance Officer
Industry
Medical / Health Care / Pharmaceuticals
Website
about.me/annaricho
About
Anna Richo acts as Chief Compliance Officer and Senior Vice President for Amgen Inc., a biopharmaceutical company based in Thousand Oaks, California. In her current role, Ms. Richo ensures that the company and its employees conduct operations in a strictly ethical manner. To that end, she remains actively involved with various aspects of manufacturing and development, sales, healthcare compliance, and reporting. In addition, Anna Richo advises the firm's Board of Directors on Amgen's progress toward improving its social and environmental commitments. Before assuming these roles, she served as Vice President, Law, for the company.
Tags
anna richo
anni richo
juvenile offenders
mandatory sentencing
people vs. ja
depaul college of law
ip programs
tip clinic
lecture
health care
depaul
social media
inc
baxter international
products and services
ucb
eular 2015
new clinical data
intellectual property
See more
Personal Information
Occupation
SVP & Chief Compliance Officer
Industry
Medical / Health Care / Pharmaceuticals
Website
about.me/annaricho
About
Anna Richo acts as Chief Compliance Officer and Senior Vice President for Amgen Inc., a biopharmaceutical company based in Thousand Oaks, California. In her current role, Ms. Richo ensures that the company and its employees conduct operations in a strictly ethical manner. To that end, she remains actively involved with various aspects of manufacturing and development, sales, healthcare compliance, and reporting. In addition, Anna Richo advises the firm's Board of Directors on Amgen's progress toward improving its social and environmental commitments. Before assuming these roles, she served as Vice President, Law, for the company.
Tags
anna richo
anni richo
juvenile offenders
mandatory sentencing
people vs. ja
depaul college of law
ip programs
tip clinic
lecture
health care
depaul
social media
inc
baxter international
products and services
ucb
eular 2015
new clinical data
intellectual property
See more